Projected Stock Price
Estimated share price by 21 August 2026.
Projected Revenue
Estimated quarterly revenue by 31 December 2026.
Projected Earnings Per Share
Estimated quarterly earnings by 31 December 2027.
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for SolarEdge Technologies, Inc.. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
In addition to being able to interpret financial data, stock analysts have connections within the companies they cover that give them access to information retail investors do not have.
Therefore, analyst ratings can help you find opportunities in the market. However, they are guidelines more than recommendations. This is why it’s important to look at analyst ratings over a period of time.
If analysts change their ratings frequently, you should pay close attention to the company’s fundamentals. For example, has there been a significant change to the company’s earnings growth and/or debt?
You should also pay attention to the number of analysts covering a stock over the course of a year. In general, the more analysts who cover the stock give the consensus rating more credibility, but each individual rating less overall weight.
Analyst ratings are one data point for you to consider. Here are some strategies you can use to fine tune your research.
Look at more than one analyst and don’t hesitate to look at analysts that have differing views. This can help challenge any preconceived ideas you have about a stock and point out ways in which your thesis for owning or avoiding a stock may have changed.
Compare a stock’s rating with other stocks in its industry or sector. In some cases, a stock is simply superior to others in its sector. However, at other times, it could be overvalued based on investor sentiment instead of fundamentals.
How are the Fintel Analyst Ratings different?Analyst ratings by Fintel are presented in close to real-time to stay ahead of generalized information flow. Combined with target price estimates and revenue estimates for the company you have greater accuracy despite market volatility.
Date | Analyst | Prior | Latest Recommendation |
Action |
---|---|---|---|---|
2024-07-15 | Susquehanna | Neutral | Neutral | Maintains |
2024-07-10 | RBC Capital | Sector Perform | Sector Perform | Reiterate |
2024-07-08 | RBC Capital | Sector Perform | Sector Perform | Maintains |
2024-07-08 | B of A Securities | Underperform | Neutral | Upgrade |
2024-05-10 | B of A Securities | Underperform | Underperform | Maintains |
2024-05-09 | BMO Capital | Market Perform | Market Perform | Maintains |
2024-05-09 | TD Cowen | Buy | Buy | Maintains |
2024-05-09 | RBC Capital | Sector Perform | Sector Perform | Maintains |
2024-05-09 | Citigroup | Neutral | Neutral | Maintains |
2024-05-09 | Canaccord Genuity | Hold | Hold | Maintains |
2024-05-09 | Goldman Sachs | Sell | Sell | Maintains |
2024-05-09 | Roth MKM | Neutral | Neutral | Maintains |
2024-05-07 | Roth MKM | Neutral | Neutral | Maintains |
2024-04-22 | B. Riley Securities | Buy | Buy | Maintains |
2024-04-19 | Mizuho | Buy | Buy | Maintains |
2024-04-17 | DZ Bank | Hold | Initiate | |
2024-04-16 | Barclays | Underweight | Underweight | Maintains |
2024-04-05 | Susquehanna | Positive | Positive | Maintains |
2024-03-22 | Janney Montgomery Scott | Buy | Neutral | Downgrade |
2024-03-11 | Piper Sandler | Neutral | Neutral | Maintains |
2024-02-22 | Mizuho | Buy | Buy | Maintains |
2024-02-22 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
2024-02-22 | Truist Securities | Hold | Hold | Maintains |
2024-02-21 | RBC Capital | Sector Perform | Sector Perform | Maintains |
2024-02-21 | BMO Capital | Market Perform | Market Perform | Maintains |
2024-02-21 | Susquehanna | Positive | Positive | Maintains |
2024-02-21 | Citigroup | Neutral | Neutral | Maintains |
2024-02-21 | Scotiabank | Sector Perform | Sector Perform | Maintains |
2024-02-21 | Canaccord Genuity | Hold | Hold | Reiterate |
2024-02-21 | Piper Sandler | Neutral | Neutral | Maintains |
2024-02-14 | RBC Capital | Sector Perform | Initiate | |
2024-02-05 | B. Riley Securities | Buy | Buy | Maintains |
2024-01-24 | Goldman Sachs | Sell | Sell | Maintains |
2024-01-23 | Truist Securities | Hold | Hold | Maintains |
2024-01-17 | Barclays | Equal-Weight | Underweight | Downgrade |
2024-01-03 | Mizuho | Buy | Buy | Maintains |
2024-07-02 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
2024-06-27 | Goldman Sachs | Sell | Sell | Maintains |
2024-06-26 | Piper Sandler | Neutral | Neutral | Maintains |
2024-06-26 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
2024-06-25 | Canaccord Genuity | Hold | Hold | Maintains |
2024-06-25 | Scotiabank | Sector Perform | Sector Perform | Maintains |
2024-06-25 | JP Morgan | Overweight | Overweight | Maintains |
2024-06-20 | JP Morgan | Overweight | Overweight | Maintains |
2024-06-07 | RBC Capital | Sector Perform | Sector Perform | Reiterate |
2024-05-15 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
2024-05-13 | Susquehanna | Positive | Neutral | Downgrade |
2024-05-10 | Deutsche Bank | Hold | Hold | Maintains |
2024-05-10 | Mizuho | Buy | Buy | Maintains |
2020-02-21 | UBS | Neutral | Maintains | |
2020-02-20 | JMP Securities | Market Outperform | Maintains | |
2020-02-20 | Cascend | Buy | Maintains | |
2020-02-20 | JP Morgan | Overweight | Maintains | |
2020-02-20 | Needham | Buy | Maintains | |
2020-01-27 | Northland Securities | Outperform | Market Perform | Downgrade |
2020-01-10 | Cascend | Buy | Reiterate | |
2019-12-02 | Needham | Buy | Initiate | |
2019-11-07 | JP Morgan | Overweight | Maintains | |
2023-12-19 | Piper Sandler | Overweight | Neutral | Downgrade |
2023-12-18 | Goldman Sachs | Neutral | Sell | Downgrade |
2023-12-07 | Roth MKM | Neutral | Neutral | Maintains |
2023-12-01 | GLJ Research | Sell | Sell | Maintains |
2023-11-30 | Citigroup | Neutral | Neutral | Maintains |
2023-11-21 | Mizuho | Buy | Initiate | |
2023-11-20 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
2023-11-08 | GLJ Research | Sell | Sell | Maintains |
2023-11-06 | Wells Fargo | Overweight | Equal-Weight | Downgrade |
2023-11-03 | Goldman Sachs | Neutral | Neutral | Maintains |
2023-11-03 | Wolfe Research | Outperform | Peer Perform | Downgrade |
2023-11-03 | Roth MKM | Neutral | Neutral | Maintains |
2023-11-02 | Susquehanna | Positive | Positive | Maintains |
2023-11-02 | JP Morgan | Overweight | Overweight | Maintains |
2023-11-02 | Exane BNP Paribas | Outperform | Neutral | Downgrade |
2023-11-02 | Citigroup | Buy | Neutral | Downgrade |
2023-11-02 | Goldman Sachs | Neutral | Neutral | Maintains |
2023-11-02 | BMO Capital | Outperform | Market Perform | Downgrade |
2023-11-02 | Guggenheim | Buy | Neutral | Downgrade |
2023-11-02 | Truist Securities | Buy | Hold | Downgrade |
2023-10-23 | Truist Securities | Buy | Buy | Maintains |
2023-10-23 | BMO Capital | Outperform | Outperform | Maintains |
2023-10-23 | Goldman Sachs | Neutral | Neutral | Maintains |
2023-10-20 | Citigroup | Buy | Buy | Maintains |
2023-10-20 | Johnson Rice | Accumulate | Hold | Downgrade |
2023-10-20 | Piper Sandler | Overweight | Overweight | Maintains |
2023-10-20 | Wells Fargo | Overweight | Overweight | Maintains |
2023-10-20 | B of A Securities | Neutral | Underperform | Downgrade |
2023-10-20 | Oppenheimer | Outperform | Perform | Downgrade |
2023-10-20 | Exane BNP Paribas | Outperform | Initiate | |
2023-10-20 | Goldman Sachs | Buy | Neutral | Downgrade |
2023-10-20 | Deutsche Bank | Buy | Hold | Downgrade |
2023-10-20 | Roth MKM | Buy | Neutral | Downgrade |
2023-10-19 | JP Morgan | Overweight | Overweight | Maintains |
2023-10-18 | Citigroup | Buy | Buy | Maintains |
2023-10-17 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
2023-10-13 | Piper Sandler | Overweight | Overweight | Maintains |
2023-10-13 | Northland Capital Markets | Market Perform | Outperform | Upgrade |
2023-10-04 | Truist Securities | Buy | Buy | Maintains |
2023-10-02 | Susquehanna | Positive | Positive | Maintains |
2023-10-02 | Barclays | Overweight | Equal-Weight | Downgrade |
2023-09-15 | JP Morgan | Overweight | Overweight | Maintains |
2023-09-12 | Truist Securities | Buy | Buy | Maintains |
2023-09-06 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
2023-08-16 | B of A Securities | Buy | Neutral | Downgrade |
2023-08-03 | Truist Securities | Buy | Buy | Maintains |
2023-08-03 | Barclays | Overweight | Overweight | Maintains |
2023-08-02 | B of A Securities | Buy | Buy | Maintains |
2023-08-02 | Susquehanna | Positive | Positive | Maintains |
2023-08-02 | BMO Capital | Outperform | Outperform | Maintains |
2023-08-02 | Goldman Sachs | Buy | Buy | Maintains |
2023-08-02 | Oppenheimer | Outperform | Outperform | Maintains |
2023-08-02 | Barclays | Overweight | Overweight | Maintains |
2023-07-19 | Citigroup | Buy | Buy | Maintains |
2023-07-18 | Barclays | Overweight | Overweight | Maintains |
2023-07-17 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
2023-07-14 | Truist Securities | Buy | Buy | Maintains |
2023-06-30 | B. Riley Securities | Buy | Buy | Maintains |
2023-05-24 | Barclays | Overweight | Overweight | Maintains |
2023-05-05 | Truist Securities | Buy | Maintains | |
2023-05-05 | Deutsche Bank | Hold | Buy | Upgrade |
2023-05-04 | BMO Capital | Outperform | Maintains | |
2023-04-25 | B. Riley Securities | Buy | Maintains | |
2023-04-19 | B of A Securities | Buy | Maintains | |
2023-04-05 | Janney Montgomery Scott | Buy | Initiate | |
2023-03-06 | Keybanc | Sector Weight | Initiate | |
2023-03-02 | Scotiabank | Sector Perform | Initiate | |
2023-02-15 | Wells Fargo | Overweight | Maintains | |
2023-02-14 | Oppenheimer | Outperform | Maintains | |
2023-02-14 | BMO Capital | Outperform | Maintains | |
2023-02-14 | JP Morgan | Overweight | Maintains | |
2023-02-10 | Truist Securities | Buy | Maintains | |
2023-02-01 | Barclays | Overweight | Maintains | |
2023-01-17 | Deutsche Bank | Hold | Maintains | |
2023-01-10 | Morgan Stanley | Equal-Weight | Maintains | |
2023-01-06 | Wells Fargo | Overweight | Maintains | |
2022-12-23 | Daiwa Capital | Neutral | Initiate | |
2022-12-22 | Piper Sandler | Overweight | Maintains | |
2022-12-14 | Barclays | Equal-Weight | Overweight | Upgrade |
2022-12-07 | B of A Securities | Neutral | Buy | Upgrade |
2022-12-05 | Cowen & Co. | Outperform | Maintains | |
2022-11-15 | Deutsche Bank | Hold | Initiate | |
2022-11-09 | Wells Fargo | Overweight | Maintains | |
2022-11-08 | Northland Capital Markets | Underperform | Market Perform | Upgrade |
2022-11-08 | BMO Capital | Outperform | Maintains | |
2022-11-08 | Needham | Buy | Maintains | |
2022-11-08 | Piper Sandler | Overweight | Maintains | |
2022-11-02 | Morgan Stanley | Equal-Weight | Maintains | |
2022-10-25 | B. Riley Securities | Buy | Maintains | |
2022-10-20 | JP Morgan | Overweight | Maintains | |
2022-10-18 | Truist Securities | Buy | Maintains | |
2022-10-17 | Piper Sandler | Overweight | Maintains | |
2022-08-18 | Morgan Stanley | Equal-Weight | Maintains | |
2022-08-08 | JP Morgan | Overweight | Maintains | |
2022-08-03 | Needham | Buy | Maintains | |
2022-07-20 | JP Morgan | Overweight | Maintains | |
2022-06-13 | Morgan Stanley | Equal-Weight | Maintains | |
2022-06-02 | Oppenheimer | Perform | Outperform | Upgrade |
2022-05-03 | Canaccord Genuity | Hold | Maintains | |
2022-05-03 | Needham | Buy | Maintains | |
2022-04-14 | Stephens & Co. | Overweight | Initiate | |
2022-03-30 | B. Riley Securities | Buy | Maintains | |
2022-03-30 | BMO Capital | Outperform | Maintains | |
2022-03-22 | Morgan Stanley | Equal-Weight | Maintains | |
2022-03-14 | Piper Sandler | Overweight | Maintains | |
2022-03-11 | B of A Securities | Buy | Maintains | |
2022-02-22 | Northland Capital Markets | Underperform | Maintains | |
2022-02-17 | Citigroup | Buy | Maintains | |
2022-02-16 | BMO Capital | Outperform | Maintains | |
2022-02-16 | Canaccord Genuity | Hold | Maintains | |
2022-02-16 | Susquehanna | Positive | Maintains | |
2022-02-08 | Wells Fargo | Overweight | Maintains | |
2022-02-03 | Needham | Hold | Buy | Upgrade |
2022-01-24 | Truist Securities | Buy | Maintains | |
2022-01-13 | Morgan Stanley | Equal-Weight | Maintains | |
2022-01-13 | Guggenheim | Neutral | Buy | Upgrade |
2022-01-10 | UBS | Sell | Neutral | Upgrade |
2021-12-21 | Citigroup | Buy | Maintains | |
2021-11-30 | Morgan Stanley | Overweight | Equal-Weight | Downgrade |
2021-11-23 | Wells Fargo | Overweight | Initiate | |
2021-10-20 | Guggenheim | Buy | Neutral | Downgrade |
2021-10-01 | BMO Capital | Outperform | Initiate | |
2021-09-01 | Wolfe Research | Outperform | Initiate | |
2021-08-19 | Morgan Stanley | Overweight | Maintains | |
2021-08-04 | Canaccord Genuity | Hold | Maintains | |
2021-08-04 | Susquehanna | Positive | Maintains | |
2021-08-03 | Goldman Sachs | Buy | Maintains | |
2021-08-03 | Johnson Rice | Hold | Accumulate | Upgrade |
2021-08-03 | Citigroup | Neutral | Buy | Upgrade |
2021-08-03 | Piper Sandler | Overweight | Maintains | |
2021-07-21 | JP Morgan | Overweight | Maintains | |
2021-07-19 | B of A Securities | Buy | Maintains | |
2021-07-15 | Piper Sandler | Overweight | Maintains | |
2021-07-02 | Goldman Sachs | Buy | Maintains | |
2021-06-25 | Citigroup | Neutral | Initiate | |
2021-06-25 | Stephens & Co. | Overweight | Initiate | |
2021-06-21 | Morgan Stanley | Overweight | Maintains | |
2021-06-03 | Guggenheim | Buy | Initiate | |
2021-05-20 | Goldman Sachs | Neutral | Buy | Upgrade |
2021-05-10 | B of A Securities | Neutral | Buy | Upgrade |
2021-05-04 | Credit Suisse | Neutral | Maintains | |
2021-05-04 | Northland Capital Markets | Underperform | Maintains | |
2021-05-04 | Roth Capital | Buy | Maintains | |
2021-05-04 | B. Riley FBR | Buy | Maintains | |
2021-04-22 | Barclays | Equal-Weight | Overweight | Upgrade |
2021-04-20 | Morgan Stanley | Overweight | Maintains | |
2021-04-06 | Tudor Pickering | Buy | Initiate | |
2021-04-01 | B of A Securities | Neutral | Initiate | |
2021-03-19 | Morgan Stanley | Overweight | Maintains | |
2021-03-19 | Susquehanna | Neutral | Positive | Upgrade |
2021-03-10 | Morgan Stanley | Overweight | Maintains | |
2021-02-18 | Canaccord Genuity | Hold | Maintains | |
2021-02-17 | Roth Capital | Buy | Maintains | |
2021-02-17 | B. Riley FBR | Buy | Maintains | |
2021-02-17 | Northland Capital Markets | Underperform | Maintains | |
2021-02-17 | Susquehanna | Neutral | Maintains | |
2021-02-09 | B. Riley FBR | Buy | Maintains | |
2021-02-04 | Roth Capital | Buy | Maintains | |
2021-01-21 | Morgan Stanley | Overweight | Initiate | |
2021-01-20 | Credit Suisse | Neutral | Maintains | |
2021-01-12 | Truist Securities | Buy | Initiate | |
2021-01-07 | Susquehanna | Positive | Neutral | Downgrade |
2020-12-11 | Piper Sandler | Overweight | Initiate | |
2020-11-03 | Northland Capital Markets | Market Perform | Underperform | Downgrade |
2020-11-03 | Oppenheimer | Outperform | Perform | Downgrade |
2020-10-27 | UBS | Neutral | Sell | Downgrade |
2020-10-26 | Credit Suisse | Neutral | Maintains | |
2020-10-16 | Goldman Sachs | Sell | Neutral | Upgrade |
2020-09-23 | B. Riley FBR | Buy | Initiate | |
2020-08-04 | Canaccord Genuity | Hold | Maintains | |
2020-08-03 | JMP Securities | Market Outperform | Market Perform | Downgrade |
2020-06-25 | Goldman Sachs | Neutral | Sell | Downgrade |
2020-05-07 | Canaccord Genuity | Buy | Hold | Downgrade |
2020-04-17 | JMP Securities | Market Outperform | Maintains | |
2020-04-07 | UBS | Neutral | Maintains | |
2020-04-02 | Needham | Buy | Hold | Downgrade |
2020-03-27 | JP Morgan | Overweight | Maintains | |
2020-03-25 | Barclays | Equal-Weight | Initiate | |
2020-02-21 | Credit Suisse | Neutral | Maintains | |
2019-11-04 | Canaccord Genuity | Buy | Maintains | |
2019-09-20 | Credit Suisse | Neutral | Maintains | |
2019-08-22 | UBS | Buy | Neutral | Downgrade |
2019-08-13 | JP Morgan | Overweight | Maintains | |
2019-06-18 | Goldman Sachs | Sell | Neutral | Upgrade |
2019-05-07 | JMP Securities | Market Underperform | Market Outperform | Upgrade |
2019-03-25 | Credit Suisse | Neutral | Initiate | |
2019-01-17 | JMP Securities | Market Perform | Market Underperform | Downgrade |
2018-11-02 | JP Morgan | Overweight | Overweight | Maintains |
2018-05-10 | JMP Securities | Market Outperform | Market Perform | Downgrade |
2018-05-08 | B. Riley FBR | Buy | Buy | Maintains |
2018-05-02 | Vertical Group | Buy | Sell | Downgrade |
2018-03-27 | Deutsche Bank | Hold | Hold | Maintains |
2018-03-19 | JP Morgan | Overweight | Overweight | Maintains |
2018-03-16 | UBS | Buy | Initiate | |
2018-02-26 | Canaccord Genuity | Buy | Buy | Maintains |
2018-02-15 | Deutsche Bank | Hold | Hold | Maintains |
2018-02-15 | Vertical Research | Hold | Buy | Upgrade |
2018-02-15 | JP Morgan | Overweight | Overweight | Maintains |
2018-01-11 | Vertical Group | Sell | Initiate | |
2017-11-27 | Deutsche Bank | Buy | Hold | Downgrade |
2017-11-09 | Canaccord Genuity | Buy | Maintains | |
2017-11-09 | B. Riley FBR | Neutral | Buy | Upgrade |
2017-11-06 | Canaccord Genuity | Buy | Maintains | |
2017-11-01 | JP Morgan | Overweight | Maintains | |
2017-08-03 | Barclays | Overweight | Maintains | |
2017-08-03 | Deutsche Bank | Buy | Maintains | |
2017-08-03 | Canaccord Genuity | Buy | Maintains | |
2017-07-27 | Roth Capital | Neutral | Buy | Upgrade |
2017-07-18 | Oppenheimer | Perform | Outperform | Upgrade |
2017-07-12 | JMP Securities | Market Outperform | Maintains | |
2017-03-03 | JMP Securities | Market Perform | Market Outperform | Upgrade |
2016-11-22 | Barclays | Overweight | Maintains | |
2016-11-14 | Craig-Hallum | Sell | Initiate | |
2016-11-10 | FBR Capital | Outperform | Market Perform | Downgrade |
2016-11-10 | Roth Capital | Buy | Neutral | Downgrade |
2016-11-10 | JMP Securities | Market Outperform | Market Perform | Downgrade |
2016-10-14 | Axiom Capial | Sell | Initiate | |
2016-10-07 | Goldman Sachs | Neutral | Sell | Downgrade |
2016-09-08 | JMP Securities | Market Outperform | Initiate | |
2016-08-10 | Deutsche Bank | Buy | Maintains | |
2016-08-10 | Barclays | Overweight | Maintains | |
2016-05-10 | Goldman Sachs | Buy | Neutral | Downgrade |
2016-04-04 | Barclays | Overweight | Initiate | |
2016-02-23 | JP Morgan | Overweight | Initiate | |
2016-02-04 | Deutsche Bank | Buy | Maintains | |
2016-01-05 | Goldman Sachs | Buy | Maintains | |
2015-12-18 | FBR Capital | Outperform | Initiate | |
2015-12-18 | Northland Securities | Outperform | Initiate | |
2015-11-16 | Avondale Partners | Market Outperform | Maintains | |
2015-11-05 | Deutsche Bank | Buy | Maintains | |
2015-11-05 | Avondale Partners | Market Perform | Outperform | Upgrade |
2015-11-02 | Roth Capital | Buy | Maintains | |
2015-08-13 | Avondale Partners | Market Perform | Market Outperform | Upgrade |
2015-05-28 | Canaccord Genuity | Buy | Maintains | |
2015-05-08 | Deutsche Bank | Buy | Maintains | |
2015-04-21 | Canaccord Genuity | Buy | Initiate | |
2015-04-20 | Deutsche Bank | Buy | Initiate | |
2015-04-20 | Needham | Buy | Initiate | |
2015-04-20 | Goldman Sachs | Buy | Initiate | |
2015-04-17 | Avondale Partners | Market Outperform | Initiate | |
2024-10-21 | TD Cowen | Buy | Hold | Downgrade |
2024-10-11 | Barclays | Underweight | Underweight | Maintains |
2024-07-17 | B of A Securities | Neutral | Neutral | Maintains |
2024-07-16 | JP Morgan | Overweight | Overweight | Maintains |
2025-07-09 | Goldman Sachs | Buy | Neutral | Downgrade |
2024-09-19 | Mizuho | Outperform | Outperform | Maintains |
2024-08-09 | Goldman Sachs | Sell | Sell | Maintains |
2024-08-09 | Deutsche Bank | Hold | Hold | Maintains |
2025-01-14 | Barclays | Underweight | Underweight | Maintains |
2024-08-06 | Truist Securities | Hold | Hold | Maintains |
2025-03-27 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
2024-07-22 | Piper Sandler | Neutral | Neutral | Maintains |
2024-10-17 | Guggenheim | Neutral | Sell | Downgrade |
2024-10-16 | Susquehanna | Neutral | Neutral | Maintains |
2024-10-17 | Piper Sandler | Neutral | Neutral | Maintains |
2024-10-21 | Roth MKM | Neutral | Neutral | Maintains |
2025-01-23 | JP Morgan | Overweight | Overweight | Maintains |
2024-11-08 | Truist Securities | Hold | Hold | Maintains |
2024-11-08 | UBS | Neutral | Neutral | Maintains |
2024-11-07 | Susquehanna | Neutral | Neutral | Maintains |
2024-11-07 | Roth MKM | Neutral | Neutral | Maintains |
2024-11-07 | Goldman Sachs | Sell | Sell | Maintains |
2024-11-07 | BMO Capital | Market Perform | Market Perform | Maintains |
2024-11-07 | TD Cowen | Hold | Hold | Maintains |
2024-11-07 | Piper Sandler | Neutral | Underweight | Downgrade |
2025-04-15 | Jefferies | Underperform | Underperform | Maintains |
2025-04-14 | Susquehanna | Neutral | Neutral | Maintains |
2024-11-29 | GLJ Research | Sell | Sell | Reiterate |
2024-10-23 | JP Morgan | Overweight | Overweight | Maintains |
2024-10-22 | Citigroup | Neutral | Neutral | Maintains |
2024-10-08 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
2024-07-23 | Roth MKM | Neutral | Neutral | Maintains |
2024-08-08 | RBC Capital | Sector Perform | Sector Perform | Maintains |
2024-08-08 | Roth MKM | Neutral | Neutral | Maintains |
2024-08-08 | B of A Securities | Neutral | Neutral | Maintains |
2024-08-08 | TD Cowen | Buy | Buy | Maintains |
2024-08-08 | Scotiabank | Sector Perform | Sector Perform | Maintains |
2024-08-08 | Truist Securities | Hold | Hold | Reiterate |
2024-08-08 | Susquehanna | Neutral | Neutral | Maintains |
2024-08-08 | Canaccord Genuity | Hold | Hold | Maintains |
2024-08-08 | Piper Sandler | Neutral | Neutral | Maintains |
2024-11-15 | Barclays | Underweight | Underperform | Maintains |
2024-11-15 | Morgan Stanley | Equal-Weight | Underweight | Downgrade |
2024-08-27 | Truist Securities | Hold | Hold | Maintains |
2024-08-29 | William Blair | Market Perform | Initiate | |
2025-08-05 | Roth Capital | Neutral | Neutral | Maintains |
2024-09-04 | Jefferies | Hold | Initiate | |
2024-09-17 | Jefferies | Hold | Underperform | Downgrade |
2025-02-20 | Morgan Stanley | Underweight | Equal-Weight | Upgrade |
2025-02-20 | UBS | Neutral | Neutral | Maintains |
2025-02-20 | Canaccord Genuity | Hold | Hold | Maintains |
2025-02-20 | RBC Capital | Sector Perform | Sector Perform | Maintains |
2025-02-20 | Goldman Sachs | Buy | Buy | Maintains |
2025-02-20 | Susquehanna | Neutral | Neutral | Maintains |
2025-02-20 | BMO Capital | Market Perform | Underperform | Downgrade |
2025-02-20 | Piper Sandler | Underweight | Underweight | Maintains |
2024-11-20 | Guggenheim | Sell | Neutral | Upgrade |
2024-10-14 | BMO Capital | Market Perform | Market Perform | Maintains |
2025-01-08 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
2025-01-08 | Citigroup | Neutral | Sell | Downgrade |
2025-02-21 | Roth MKM | Neutral | Neutral | Maintains |
2025-02-21 | Jefferies | Underperform | Underperform | Maintains |
2025-05-07 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
2025-05-07 | JP Morgan | Overweight | Overweight | Maintains |
2025-05-07 | Canaccord Genuity | Hold | Hold | Maintains |
2025-05-21 | GLJ Research | Sell | Sell | Maintains |
2025-04-16 | Barclays | Underweight | Underweight | Maintains |
2024-10-10 | B of A Securities | Neutral | Neutral | Maintains |
2025-01-16 | Truist Securities | Hold | Hold | Maintains |
2024-10-15 | RBC Capital | Sector Perform | Sector Perform | Maintains |
2025-01-07 | Canaccord Genuity | Hold | Hold | Maintains |
2025-01-07 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
2025-01-07 | Goldman Sachs | Buy | Buy | Maintains |
2025-04-24 | Guggenheim | Neutral | Sell | Downgrade |
2025-06-11 | Barclays | Underweight | Underweight | Maintains |
2025-06-17 | Keybanc | Sector Weight | Underweight | Downgrade |
2025-06-17 | GLJ Research | Hold | Sell | Downgrade |
2025-08-19 | UBS | Neutral | Neutral | Maintains |
2025-05-30 | GLJ Research | Sell | Hold | Upgrade |
2025-05-08 | UBS | Neutral | Neutral | Maintains |
2025-08-08 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
2025-06-02 | Mizuho | Neutral | Neutral | Maintains |
2025-06-10 | UBS | Neutral | Neutral | Maintains |
2025-07-08 | Keybanc | Underweight | Sector Weight | Upgrade |
2025-07-14 | Jefferies | Underperform | Underperform | Maintains |
2025-07-14 | Mizuho | Neutral | Neutral | Maintains |
2025-07-14 | Barclays | Underweight | Equal-Weight | Upgrade |
2025-07-15 | JP Morgan | Overweight | Neutral | Downgrade |
2025-07-21 | Susquehanna | Neutral | Neutral | Maintains |
2025-08-25 | Guggenheim | Sell | Sell | Maintains |
Revenue Estimates
The forecasted annual revenue of SolarEdge Technologies, Inc. in 2031-12-31 is 4,386MM. )
Understanding a company’s revenue history gives investors a snapshot of its potential growth. Revenue growth is a solid predictor of earnings (or profit) growth. A company that can increase its revenue while keeping its operating costs constant has more available capital to reinvest into its business or return to shareholders through dividends or share buybacks.
However, investors should be careful before investing in a company that is growing revenue but showing declining earnings or is unprofitable. In some cases, this is simply a case of a young company that is still in an early growth phase. But if this is a mature company, it can indicate that other fundamental problems exist.
Fintel gives you revenue projections for stocks that cover 10 years between 2020 and 2030. Although past performance does not guarantee future results, you can be more confident in your decision to buy or sell a stock when you see a company with revenue that has a track record of increasing its revenue.
Update Frequency: Quarterly
Date | Revenue Average Quarterly (MM) | Number of Analysts (Quarterly) | Revenue Average Annually (MM) | Number of Analysts (Annually) |
---|---|---|---|---|
2025-09-30 | 1,581 | 7 | -- | -- |
2025-12-31 | 1,676 | 7 | 5,943 | 16 |
2026-03-31 | 872 | 4 | -- | -- |
2026-06-30 | 857 | 4 | -- | -- |
2026-09-30 | 913 | 4 | -- | -- |
2026-12-31 | 862 | 6 | 6,391 | 4 |
2027-12-31 | -- | -- | 7,112 | 4 |
2028-12-31 | -- | -- | 7,852 | 4 |
2029-12-31 | -- | -- | 8,618 | 4 |
2030-12-31 | -- | -- | 9,043 | 4 |
2031-12-31 | -- | -- | 4,386 | 4 |
Earnings Estimates
The forecasted annual earnings of SolarEdge Technologies, Inc. in 2032-12-31 is 4.69 per share.
One part of an analyst’s rating is a profit (i.e., earnings) estimate for the current quarter and/or future quarters. The measurement given is earnings per share (EPS). EPS is a metric that indicates how much a company earned as represented by one share of its stock over a specific period (typically three months).
To understand the earnings per share calculation, you must understand net income. Net income is the amount of money a company has left over after deducting appropriate expenses and taxes from its revenues).
The formula for earnings per share is net income divided by the total number of outstanding shares (i.e., available for purchase). For example:
Company A has a net income of $100 million and forty million outstanding shares. The EPS calculation is as follows:
100,000,000/40,000,000 = $2.50 per share
Earnings per share is an essential metric for you to consider when deciding to buy a stock. After all, a company with high earnings per share is productive and generates revenue in excess of its operating costs.
However, it’s not the only metric you should use. Metrics like price-to-earnings and debt-to-equity add additional perspective about a company’s health.
You should also be sure to compare a company’s EPS with a company in its sector. However, when you do, be aware that EPS is different and more important than net profit by itself. You may see a company that has a rising net profit. But if its outstanding shares are also rising, then its EPS might be flat or even edging lower.
Update Frequency: Quarterly
Date | EPS Average (Quarterly) | Number of Analysts (Quarterly) | EPS Average (Annual) | Number of Analysts (Annually) |
---|---|---|---|---|
2025-09-30 | 3.69 | 7 | -- | -- |
2025-12-31 | 4.10 | 7 | 14.07 | 16 |
2026-03-31 | 2.68 | 3 | -- | -- |
2026-06-30 | 2.20 | 3 | -- | -- |
2026-09-30 | 2.57 | 3 | -- | -- |
2026-12-31 | 1.84 | 6 | 15.34 | 4 |
2027-03-31 | 0.97 | 3 | -- | -- |
2027-06-30 | 1.00 | 3 | -- | -- |
2027-09-30 | 1.05 | 3 | -- | -- |
2027-12-31 | 0.81 | 6 | 17.40 | 4 |
2028-12-31 | -- | -- | 19.19 | 4 |
2029-12-31 | -- | -- | 20.93 | 4 |
2030-12-31 | -- | -- | 25.58 | 4 |
2031-12-31 | -- | -- | 8.62 | 4 |
2032-12-31 | -- | -- | 4.69 | 3 |
EBITDA Estimates
The forecasted annual EBITDA of SolarEdge Technologies, Inc. in 2028-12-31 is 972MM.
EBIDTA is an acronym that stands for earnings before interest, taxes, depreciation, and amortization. Analysts and investors pay attention to EBITDA because it strips out items that a company must report on its balance sheet but doesn’t significantly impact its business. Here’s an explanation of what that means for each part of the acronym:
Interest: Loan interest and earnings are subject to change based on a company’s financial strategy and, in any event, are not part of its core activities.
Taxes: Taxes are affected by governmental policy that can distort a company’s perceived profitability.
Depreciation: This accounts for the expected depreciation on tangible assets and immaterial goods from company investments. But since these investments may ultimately increase a company’s efficiency and profit potential, they aren’t a good indicator of a company’s current profitability.
Amortization: This shows the gradual writing off of the initial cost of an asset. It differs from depreciation because it is typically used with intangible assets such as intellectual property (e.g., patents, copyrights, etc.)
EBITDA vs. Net IncomeNet income is the profit a company has left over after covering its operating expenses. However, net income includes the items that EBITDA excludes. That’s why most analysts prefer EBITDA because it better reflects the health of a company’s core business.
Update Frequency: Quarterly
EBIT Estimates
The forecasted annual EBIT of SolarEdge Technologies, Inc. in 2028-12-31 is 679MM.
EBIT is an acronym that stands for earnings before interest and taxes. Analysts use EBIT to measure a company’s performance because it strips out tax expenses and the costs of the capital structure influencing profit. These don’t significantly impact a company’s business.
Interest: Loan interest and earnings are subject to change based on a company’s financial strategy and, in any event, are not part of its core activities.
Taxes: Taxes are affected by governmental policy that can distort a company’s perceived profitability.
NOTE: EBIT is sometimes synonymous with operating income. However, in some cases, operating income doesn’t include gains or losses from non-core activities.
EBITDA also strips out depreciation and amortization from a company’s earnings:
Depreciation: This accounts for the expected depreciation on tangible assets and immaterial goods from company investments. But since these investments may ultimately increase a company’s efficiency and profit potential, they aren’t a good indicator of a company’s current profitability.
Amortization: This shows the gradual writing off of the initial cost of an asset. It differs from depreciation because it is typically used with intangible assets such as intellectual property (e.g., patents, copyrights, etc.)
Update Frequency: Quarterly